A new treatment for retroperitoneal fibrosis: initial experiences of using Seprafilm® to wrap the ureter.

Objective: To confirm the efficacy of using Seprafilm® (Genzyme Corp., Cambridge, MA, USA) for wrapping the ureter to treat the ureteric stenosis caused by retroperitoneal fibrosis (RPF).

Patients And Methods: Between August 2010 and September 2012, 11 ureters in eight patients with RPF (seven males and one female, mean age 65 years) were treated.